Children, Management, Supraventricular Arrhythmias
Conditions
Keywords
supraventricular arrhythmias, supraventricular tachycardia, children
Brief summary
Background Supraventricular tachycardias (SVTs) are the most common arrhythmic events in children, with an estimated incidence of 13 per 100,000 per year before the age of 18. Few large patient cohorts have been reported, as most published studies are single-center. Large-scale studies come from medico-administrative databases, which lack the granularity needed for detailed analysis of outcomes according to the therapies used and the type of SVT. Furthermore, although a large proportion of neonatal SVTs do not recur (spontaneous resolution of the accessory pathway), there are limited comparative data on the effectiveness of antiarrhythmic therapies specifically in children after the age of 1 year. Management therefore varies greatly, in part because current guidelines propose different therapeutic options based on low-level evidence. Objectives: * Describe the management of SVTs (antiarrhythmic therapies and catheter ablation) in children in France * Compare the effectiveness of different antiarrhythmic treatments according to age (\<1 year and \>1 year) and type of SVT * Analyze the incidence of adverse events and complications associated with antiarrhythmic treatments and catheter ablation
Interventions
OTHERManagement of children with supraventricular tachycardias
Observational analysis of the management of supraventricular tachycardias (antiarrhythmic drugs and catheter ablations)
Sponsors
Paris Cardiovascular Research Center (Inserm U970)
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
0 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* Age \<18 years at the time of the first documented supraventricular tachycardia episode
Exclusion criteria
* Early postoperative supraventricular tachycardia (\<30 days) * Age ≥18 years at the first documented supraventricular tachycardia episode * Fetal tachycardias without postnatal recurrence * Atrial extrasystoles without sustained runs (\<30 seconds)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Antiarrhythmic therapies | At the time of the first supraventricular tachycardia recorded | Proportion of antiarrhythmic therapies used by age group (\<1 year and \>1 year) |
| Catheter ablation | At the time of first episode of supraventricular tachycardia or after recurrence | Proportion of children referred for catheter ablation and age at ablation |
| Recurrence of supraventricular tachycardia | At 1 year after antiarrhythmic drug initiation | Time between antiarrhythmic therapy initiation and first recurrence, according to treatment and age |
Outcome results
None listed